Non-Hodgkin's lymphoma of the nasopharynx: CT and MR Imaging

被引:51
|
作者
King, AD [1 ]
Lei, KIK
Richards, PS
Ahuja, AT
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Diagnost Radiol & Organ Imaging, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[3] Royal London Hosp, London E1 1BB, England
关键词
CT; MRI; head and neck; lymphoma;
D O I
10.1016/S0009-9260(03)00182-X
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE: Nasopharyngeal (NP) non-Hodgkin's lymphoma (NHL) is an uncommon tumour. The aim of the study was to describe the appearances on CT and MR imaging, and identify the features which help to distinguish NPNHL from other NP tumours. MATERIALS AND METHODS: The CT (n = 8) and MR (n = 10) images of 14 patients with NPNHL were reviewed retrospectively. Patients with NPNHL were divided into primary NPNHL, where the primary tumour was in the NP (n = 7) and secondary NPNHL where the primary tumour was at another extranodal site in the head and neck (n = 7). All NPNHL were assessed for tumour size and distribution, appearance and local tumour invasion, in addition lymphadenopathy was assessed in primary NPNHL. RESULTS: The NPNHL ranged in size from 20-75 mm (mean of 55 mm for primary and 30 mm for secondary NHL) and were homogeneous on CT in eight (100%) and MR in seven (70%) and mildly heterogeneous on MR in three (30%) patients. NPNHL involved all walls of the NP in 10 (71%) and extended in an exophytic fashion to fill the NP cavity in six (43%). Deep tumour invasion was present in two (14%) both patients with primary NHL, the extent and volume of this tumour invasion was small and involved the prevertebral muscles (n = 2), parapharyngeal fat space (n = 1) and skull base (n = 1). Primary NPNHL extended superficially in five (71%) to involve the nasal cavity (n = 3) and oropharynx (n = 2) and lymphadenopathy was present in five (71%) being bilateral and involving multiple nodal sites (n = 4) with necrosis (n = 2) and matting (n = 3). CONCLUSION: NPNHL is a homogeneous tumour that tends to diffusely involve all walls of the nasopharynx and spread in an exophytic fashion to fill the airway, rather than infiltrating into the deep tissues. Deep tumour infiltration, when it occurs, is found in those patients with primary NHL and is usually limited in extent and of small volume. Primary NHL more commonly spreads superficially to involve the nasal cavity or oropharynx, lymphadenopathy is frequent and extensive. A large tumour that fills the nasopharynx, with no or minimal invasion into deep structures, and a propensity to extend down into the tonsil, rather than up into the skull base, may suggest the diagnosis of NHL over nasopharyngeal carcinoma. (C) 2003 The Royal College of Radiologists. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:621 / 625
页数:5
相关论文
共 50 条
  • [31] Multifocal non-Hodgkin lymphoma in an infant with cardiac involvement: whole-body MR imaging
    Kumar, Jyoti
    Seith, Ashu
    Bakhshi, Sameer
    Sharma, Raju
    Kumar, Atin
    PEDIATRIC RADIOLOGY, 2007, 37 (03) : 321 - 324
  • [32] Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree
    Alexandrescu, Doru T.
    Garino, Alexandria
    Brown-Balem, Kelly A.
    Wiernik, Peter H.
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2115 - 2127
  • [33] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Schiepers, Christiaan
    Filmont, Jean-Emmanuel
    Czernin, Johannes
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S82 - S88
  • [34] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [35] Extranodal Non-Hodgkin's Lymphoma in HIV
    Rizwan, Mian Muhammad
    Gaba, Parveen
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (07) : 733 - 734
  • [36] Chemokines and antagonists in non-Hodgkin's lymphoma
    Golay, Josee
    Introna, Martino
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (05) : 621 - 635
  • [37] Ibritumomab tiuxetan for non-Hodgkin's lymphoma
    Johnston, Patrick B.
    Bondly, Cara
    Micallef, Ivana N. M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 861 - 869
  • [38] New drugs in non-Hodgkin's lymphoma
    Arbuck, SG
    Sorensen, JM
    Christian, MC
    Ho, P
    Pluda, JM
    Cheson, BD
    ANNALS OF ONCOLOGY, 1997, 8 : 119 - 128
  • [39] Neurologic complications of non-Hodgkin's lymphoma
    Giglio P.
    Gilbert M.R.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 214 - 219
  • [40] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41